ribavirin has been researched along with transforming growth factor beta in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Germer, JJ; Vidigal, PG; Zein, NN | 1 |
| Akremi, R; Asselah, T; Benali, S; Benhamou, JP; Bourliere, M; Boyer, N; Ibrahim, A; Katz, GG; Le Breton, V; Le Guludec, G; Lecomte, L; Malkiewicz, I; Marcellin, P; Martinot-Peignoux, M; Neuman, MG; Shear, NH | 1 |
| Beniowski, M; Borgiel-Marek, H; Fila, A; Filipczyk, P; Janczewska-Kazek, E; Kajdaniuk, D; Kajdaniuk, J; Kos-Kudla, B; Marek, B; Mazurek, U; Niedziolka, D; Nowak, M; Ostrowska, Z; Pakula, D; Sieminska, L; Strzalka, B; Wilczok, T | 1 |
| Flisiak, I; Flisiak, R; Jaroszewicz, J; Lapinski, TW; Prokopowiczi, D | 1 |
| Borgiel-Marek, H; Janczewska-Kazek, E; Kajdaniuk, D; Marek, B | 1 |
| Capelli, P; Corrocher, R; De Franceschi, L; Fattovich, G; Felder, M; Guido, M; Lanza, C; Leandro, G; Olivari, N; Pasino, M; Rugge, M | 1 |
| Adams, LA; Bulsara, M; Cheng, W; Flexman, JP; Lee, S; Price, P; Rossi, E; Varano, J; Watson, MW | 1 |
| Boonstra, A; Claassen, MA; de Knegt, RJ; Groothuismink, ZM; Janssen, HL; Turgut, D | 1 |
| Honda, M; Kaneko, S; Lemon, SM; Murai, K; Murakami, S; Okada, H; Sakai, Y; Shimakami, T; Shiomoto, T; Shirasaki, T; Takabatake, R; Tokumaru, A; Yamashita, T | 1 |
| Del Rincon, SV; Dobocan, MC; Emond, A; Huor, B; Miller, WH; Ng, J; Ngan, E; Pettersson, F; Siegel, PM | 1 |
| Bukowska-Ośko, I; Cortes, KC; Inglot, M; Jabłońska, J; Laskus, T; Osowska, S; Pawełczyk, A; Pawłowski, T; Perlejewski, K; Radkowski, M; Ząbek, P; Zalewska, M | 1 |
| Arientová, S; Beran, O; Boštík, P; Chalupa, P; Davidová, A; Holub, M; Kapla, J; Kondělková, K; Plíšek, S | 1 |
| Gaballah, AH; Ghazy, AA; Mostafa, H; Osman, EM; Rashwan, EA; Tawfik, S | 1 |
2 trial(s) available for ribavirin and transforming growth factor beta
| Article | Year |
|---|---|
Serum tumour necrosis factor-alpha and transforming growth factor-beta levels in chronic hepatitis C patients are immunomodulated by therapy.
Topics: Adult; Alanine Transaminase; Antiviral Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Transforming Growth Factor beta; Treatment Outcome; Tumor Necrosis Factor-alpha | 2002 |
The correlation between pretreatment cytokine expression patterns in peripheral blood mononuclear cells with chronic hepatitis C outcome.
Topics: Adult; Aged; Antiviral Agents; Cytokines; Female; Gene Expression Profiling; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interleukins; Leukocytes, Mononuclear; Male; Middle Aged; Ribavirin; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2015 |
11 other study(ies) available for ribavirin and transforming growth factor beta
| Article | Year |
|---|---|
Polymorphisms in the interleukin-10, tumor necrosis factor-alpha, and transforming growth factor-beta1 genes in chronic hepatitis C patients treated with interferon and ribavirin.
Topics: Adult; Aged; Antiviral Agents; Female; Genotype; Hepatitis C, Chronic; Humans; Immunity, Innate; Interferons; Interleukin-10; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Ribavirin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome; Tumor Necrosis Factor-alpha | 2002 |
TGF-beta1 mRNA expression in liver biopsy specimens and TGF-beta1 serum levels in patients with chronic hepatitis C before and after antiviral therapy.
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver; Male; Recombinant Proteins; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effect of pegylated interferon alpha 2b plus ribavirin treatment on plasma transforming growth factor-beta1, metalloproteinase-1, and tissue metalloproteinase inhibitor-1 in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Drug Carriers; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Matrix Metalloproteinase 1; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Statistics as Topic; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2005 |
Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-beta1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C.
Topics: Adult; Antiviral Agents; Biomarkers; Female; Fibroblast Growth Factor 2; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prognosis; Ribavirin; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vascular Endothelial Growth Factor A | 2006 |
Effects of interferon plus ribavirin treatment on NF-kappaB, TGF-beta1, and metalloproteinase activity in chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Biomarkers; Drug Therapy, Combination; Female; Fibrosis; Hepatitis C, Chronic; Humans; Interferon-alpha; Liver; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Metalloproteases; Middle Aged; NF-kappa B; Retrospective Studies; Ribavirin; Tissue Inhibitor of Metalloproteinase-1; Transforming Growth Factor beta; Transforming Growth Factor beta1; Treatment Outcome | 2006 |
Decreased IP-10 and elevated TGFbeta1 levels are associated with viral clearance following therapy in patients with hepatitis C virus.
Topics: Adult; Aged; Algorithms; Antiviral Agents; Area Under Curve; Chemokine CXCL10; Extracellular Matrix Proteins; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sensitivity and Specificity; Transforming Growth Factor beta; Treatment Outcome; Viral Load | 2010 |
Negative regulation of hepatitis C virus specific immunity is highly heterogeneous and modulated by pegylated interferon-alpha/ribavirin therapy.
Topics: Adult; Antiviral Agents; Cell Proliferation; Hepacivirus; Hepatitis C, Chronic; Humans; Immunity, Cellular; Interferon-alpha; Interleukin-10; Male; Middle Aged; Ribavirin; RNA, Viral; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Virus Replication | 2012 |
Impaired interferon signaling in chronic hepatitis C patients with advanced fibrosis via the transforming growth factor beta signaling pathway.
Topics: Adult; Aged; Amino Acids; Animals; Antiviral Agents; Cell Line, Tumor; Dietary Supplements; Drug Therapy, Combination; Female; Forkhead Box Protein O3; Forkhead Transcription Factors; Gene Expression Regulation; Hepatitis C, Chronic; Humans; Interferons; Interleukins; Liver; Liver Cirrhosis; Male; Mechanistic Target of Rapamycin Complex 1; Mice; Middle Aged; Multiprotein Complexes; Nutritional Status; Proto-Oncogene Proteins c-jun; Ribavirin; Suppressor of Cytokine Signaling 3 Protein; Suppressor of Cytokine Signaling Proteins; TOR Serine-Threonine Kinases; Transforming Growth Factor beta | 2014 |
Genetic and pharmacologic inhibition of eIF4E reduces breast cancer cell migration, invasion, and metastasis.
Topics: Animals; Breast Neoplasms; Cell Line, Tumor; Cell Movement; Epithelial-Mesenchymal Transition; Eukaryotic Initiation Factor-4E; Female; Humans; Lung Neoplasms; Matrix Metalloproteinase 9; Mice; Mice, Inbred BALB C; Neoplasm Invasiveness; Ribavirin; Transforming Growth Factor beta | 2015 |
Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta.
Topics: ADP-ribosyl Cyclase 1; Adult; Aged; Antiviral Agents; CD8-Positive T-Lymphocytes; Female; Flow Cytometry; Genotype; Hepacivirus; Hepatitis C, Chronic; HLA-DR Antigens; Humans; Immunophenotyping; Interferon-alpha; Lymphocyte Activation; Male; Membrane Glycoproteins; Middle Aged; Protease Inhibitors; Ribavirin; Serum; T-Lymphocytes, Regulatory; Transforming Growth Factor beta; Young Adult | 2016 |
Relation between microRNA-21, transforming growth factor β and response to treatment among chronic hepatitis C patients.
Topics: Adult; Antiviral Agents; Biomarkers; Carbamates; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Male; MicroRNAs; Middle Aged; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Transforming Growth Factor beta; Treatment Outcome; Valine; Viral Load | 2019 |